News

Amgen's weight-loss drug MariTide had a successful Phase 2 trial so the company is expanding development plans to study its use for heart disease and sleep apnea.
U.S. stocks were trading near session highs Monday afternoon, putting the S&P 500 closer to record territory. The risk-on tone was attributed to a diminished "fear factor" in markets since the U.S.'s ...
S&W Seed terminated all non-essential employees to reduce costs and is considering strategic alternatives potentially including bankruptcy or a dissolution and liquidation of the company. Shares ...
Is the Federal Reserve suddenly open to cutting U.S. interest rates as early as July? That’s what Wall Street investors want ...